Manufacturer
109 recalls in our database name Ameditech Inc as the manufacturing or recalling firm.
Of the 109 recalls from Ameditech Inc we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Ameditech is recalling Alere iScreen Dx Urine Drug Screen Cards because the box label incorrectly lists Phencyclidine (PCP) instead of Tricyclic Antidepressants (TCA).
Ameditech Inc is recalling Alere iScreen Dx Urine Drug Screen Cards because the kit box label incorrectly identifies PCP instead of TCA as a drug analyte.
Ameditech is recalling DrugSmart Cup 10 units because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ImmuTest 12 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling 492 ProScreen CLIA Waived Cup kits due to reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling 10,320 CLIA RDTC 12-Panel Cup kits nationwide because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 10 Drug Panel Cassette Tests because they may show reduced reactivity for specific benzodiazepine compounds.
Ameditech is recalling ProScreen 12 Panel Cups because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling Immutest 11 Pnl Drug Screen Cups because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling ProScreen 10 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen CLIA Waived Cup kits because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling 340 DrugSmart 10 Test Cup kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling DrugSmart Cup drug tests because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling 1,680 ProScreen CLIA Wvd 12 Panel Cup kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ImmuTest Cup 7-panel drug tests because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling DrugSmart 11 Test Cups because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling Immutest Cup CLIA Waived kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 12 Drug Cups because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling 1,907 DrugCheck Waived 12 Panel Cup kits nationwide due to reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen CLIA Waived Cup 6 Drugs kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 7 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling 82 kits of ProScreen 8 Panel Dip Cards because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling ProScreen 12 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling Immutest 10 Pnl Drug Screen Cups because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling 96 kits of ProScProScreen 10 Panel Cups due to reduced reactivity for two benzodiazepine compounds.